Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1994 Apr;111(4):1017–1022. doi: 10.1111/j.1476-5381.1994.tb14845.x

Characterization of the capsaicin-sensitive component of cyclophosphamide-induced inflammation in the rat urinary bladder.

A Ahluwalia 1, C A Maggi 1, P Santicioli 1, A Lecci 1, S Giuliani 1
PMCID: PMC1910135  PMID: 8032584

Abstract

1. Cyclophosphamide (CYP) (150 mg kg-1, i.p. 0.5-48 h before) caused a time-dependent plasma protein extravasation in the rat urinary bladder with the maximal extravasation occurring at between 2 and 4 h after administration of the drug. 2. Prior capsaicin desensitization of capsaicin-sensitive primary afferent neurones (CSPANs) (50 mg kg-1, s.c., 4 days before) resulted in approximately 50% inhibition of the magnitude of the extravasation response at the 2 h time-point. 3. Intraperitoneal (i.p.) pretreatment with the tachykinin NK1 receptor antagonist, RP 67,580 (0.44 mg kg-1) or the bradykinin B2 receptor antagonist, Hoe 140 (0.13 mg kg-1) had significant inhibitory effects, giving responses of 56 +/- 6% and 39 +/- 4% of the control extravasation response to CYP treatment after 2 h. Pretreatment with the tachykinin NK2 receptor antagonist, SR 48,968 (0.3 mg kg-1, i.p.), the histamine H1 receptor blocker, chlorpheniramine (10 mg kg-1, i.p.), the 5-HT receptor blocker, methysergide (6 mg kg-1, i.p.) or the cyclo-oxygenase inhibitor indomethacin (5 mg kg-1, i.p.) had no significant effect upon the development of the extravasation response at this same time-point. 4. In rat isolated urinary bladder strips, the active metabolite of CYP, acrolein (1-300 microM) produced a concentration-dependent contraction that was significantly reduced by in vitro capsaicin desensitization (10 microM for 15 min) indicating direct stimulation of CSPANs. CYP was without appreciable effect. 5. The effect of acrolein in vitro was significantly reduced by pretreatment of the bladder with a combination of tachykinin NK1 and NK2 receptor antagonists, RP 67,580 (3 microM) and SR 48,968 (1 microM). The dose-response curve to acrolein was also significantly inhibited by treatment with indomethacin (10 microM) and slightly affected by Hoe 140 (1 microM).(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
1017

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chahl L. A. Antidromic vasodilatation and neurogenic inflammation. Pharmacol Ther. 1988;37(2):275–300. doi: 10.1016/0163-7258(88)90029-0. [DOI] [PubMed] [Google Scholar]
  2. Cox P. J. Cyclophosphamide cystitis--identification of acrolein as the causative agent. Biochem Pharmacol. 1979 Jul 1;28(13):2045–2049. doi: 10.1016/0006-2952(79)90222-3. [DOI] [PubMed] [Google Scholar]
  3. Eglezos A., Giuliani S., Viti G., Maggi C. A. Direct evidence that capsaicin-induced plasma protein extravasation is mediated through tachykinin NK1 receptors. Eur J Pharmacol. 1991 Dec 17;209(3):277–279. doi: 10.1016/0014-2999(91)90183-q. [DOI] [PubMed] [Google Scholar]
  4. Eglezos A., Lecci A., Santicioli P., Giuliani S., Tramontana M., Del Bianco E., Maggi C. A. Activation of capsaicin-sensitive primary afferents in the rat urinary bladder by compound 48/80: a direct action on sensory nerves? Arch Int Pharmacodyn Ther. 1992 Jan-Feb;315:96–109. [PubMed] [Google Scholar]
  5. Fraiser L. H., Kanekal S., Kehrer J. P. Cyclophosphamide toxicity. Characterising and avoiding the problem. Drugs. 1991 Nov;42(5):781–795. doi: 10.2165/00003495-199142050-00005. [DOI] [PubMed] [Google Scholar]
  6. Garret C., Carruette A., Fardin V., Moussaoui S., Peyronel J. F., Blanchard J. C., Laduron P. M. Pharmacological properties of a potent and selective nonpeptide substance P antagonist. Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):10208–10212. doi: 10.1073/pnas.88.22.10208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Giuliani S., Santicioli P., Lippe I. T., Lecci A., Maggi C. A. Effect of bradykinin and tachykinin receptor antagonist on xylene-induced cystitis in rats. J Urol. 1993 Sep;150(3):1014–1017. doi: 10.1016/s0022-5347(17)35677-x. [DOI] [PubMed] [Google Scholar]
  8. Giuliani S., Santicioli P., Tramontana M., Geppetti P., Maggi C. A. Peptide N-formyl-methionyl-leucyl-phenylalanine (FMLP) activates capsaicin-sensitive primary afferent nerves in guinea-pig atria and urinary bladder. Br J Pharmacol. 1991 Mar;102(3):730–734. doi: 10.1111/j.1476-5381.1991.tb12241.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Grinberg-Funes D. J., Sheldon C., Weiss M. The use of prostaglandin F2 alpha for the prophylaxis of cyclophosphamide induced cystitis in rats. J Urol. 1990 Dec;144(6):1500–1504. doi: 10.1016/s0022-5347(17)39786-0. [DOI] [PubMed] [Google Scholar]
  10. Holzer P. Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons. Pharmacol Rev. 1991 Jun;43(2):143–201. [PubMed] [Google Scholar]
  11. Lee B. P., Morton R. F., Lee L. Y. Acute effects of acrolein on breathing: role of vagal bronchopulmonary afferents. J Appl Physiol (1985) 1992 Mar;72(3):1050–1056. doi: 10.1152/jappl.1992.72.3.1050. [DOI] [PubMed] [Google Scholar]
  12. Lembeck F., Griesbacher T., Eckhardt M., Henke S., Breipohl G., Knolle J. New, long-acting, potent bradykinin antagonists. Br J Pharmacol. 1991 Feb;102(2):297–304. doi: 10.1111/j.1476-5381.1991.tb12169.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Maggi C. A., Abelli L., Giuliani S., Santicioli P., Geppetti P., Somma V., Frilli S., Meli A. The contribution of sensory nerves to xylene-induced cystitis in rats. Neuroscience. 1988 Aug;26(2):709–723. doi: 10.1016/0306-4522(88)90176-5. [DOI] [PubMed] [Google Scholar]
  14. Maggi C. A., Geppetti P., Santicioli P., Frilli S., Giuliani S., Furio M., Theodorsson E., Fusco B., Meli A. Tachykinin-like immunoreactivity in the mammalian urinary bladder: correlation with the functions of the capsaicin-sensitive sensory nerves. Neuroscience. 1988 Jul;26(1):233–242. doi: 10.1016/0306-4522(88)90140-6. [DOI] [PubMed] [Google Scholar]
  15. Maggi C. A., Lecci A., Santicioli P., Del Bianco E., Giuliani S. Cyclophosphamide cystitis in rats: involvement of capsaicin-sensitive primary afferents. J Auton Nerv Syst. 1992 May 15;38(3):201–208. doi: 10.1016/0165-1838(92)90031-b. [DOI] [PubMed] [Google Scholar]
  16. Maggi C. A., Patacchini R., Santicioli P., Geppetti P., Cecconi R., Giuliani S., Meli A. Multiple mechanisms in the motor responses of the guinea-pig isolated urinary bladder to bradykinin. Br J Pharmacol. 1989 Oct;98(2):619–629. doi: 10.1111/j.1476-5381.1989.tb12636.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Maggi C. A., Patacchini R., Santicioli P., Giuliani S. Tachykinin antagonists and capsaicin-induced contraction of the rat isolated urinary bladder: evidence for tachykinin-mediated cotransmission. Br J Pharmacol. 1991 Jun;103(2):1535–1541. doi: 10.1111/j.1476-5381.1991.tb09823.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Maggi C. A., Santicioli P., Abelli L., Parlani M., Capasso M., Conte B., Giuliani S., Meli A. Regional differences in the effects of capsaicin and tachykinins on motor activity and vascular permeability of the rat lower urinary tract. Naunyn Schmiedebergs Arch Pharmacol. 1987 Jun;335(6):636–645. doi: 10.1007/BF00166980. [DOI] [PubMed] [Google Scholar]
  19. Maggi C. A., Santicioli P., Borsini F., Giuliani S., Meli A. The role of the capsaicin-sensitive innervation of the rat urinary bladder in the activation of micturition reflex. Naunyn Schmiedebergs Arch Pharmacol. 1986 Mar;332(3):276–283. doi: 10.1007/BF00504867. [DOI] [PubMed] [Google Scholar]
  20. Maggi C. A., Santicioli P., Del Bianco E., Lecci A., Guliani S. Evidence for the involvement of bradykinin in chemically-evoked cystitis in anaesthetized rats. Naunyn Schmiedebergs Arch Pharmacol. 1993 Apr;347(4):432–437. doi: 10.1007/BF00165395. [DOI] [PubMed] [Google Scholar]
  21. Maggi C. A., Santicioli P., Patacchini R., Geppetti P., Giuliani S., Astolfi G. M., Baldi E., Parlani M., Theodorsson E., Fusco B. Regional differences in the motor response to capsaicin in the guinea-pig urinary bladder: relative role of pre- and postjunctional factors related to neuropeptide-containing sensory nerves. Neuroscience. 1988 Nov;27(2):675–688. doi: 10.1016/0306-4522(88)90297-7. [DOI] [PubMed] [Google Scholar]
  22. Maggi C. A. The pharmacology of the efferent function of sensory nerves. J Auton Pharmacol. 1991 Jun;11(3):173–208. doi: 10.1111/j.1474-8673.1991.tb00317.x. [DOI] [PubMed] [Google Scholar]
  23. Maggi C. A. The role of peptides in the regulation of the micturition reflex: an update. Gen Pharmacol. 1991;22(1):1–24. doi: 10.1016/0306-3623(91)90304-o. [DOI] [PubMed] [Google Scholar]
  24. PHILIPS F. S., STERNBERG S. S., CRONIN A. P., VIDAL P. M. Cyclophosphamide and urinary bladder toxicity. Cancer Res. 1961 Dec;21:1577–1589. [PubMed] [Google Scholar]
  25. Santicioli P., Giuliani S., Maggi C. A. Failure of L-nitroarginine, a nitric oxide synthase inhibitor, to affect hypotension and plasma protein extravasation produced by tachykinin NK-1 receptor activation in rats. J Auton Pharmacol. 1993 Jun;13(3):193–199. doi: 10.1111/j.1474-8673.1993.tb00266.x. [DOI] [PubMed] [Google Scholar]
  26. Saria A., Lundberg J. M. Evans blue fluorescence: quantitative and morphological evaluation of vascular permeability in animal tissues. J Neurosci Methods. 1983 May;8(1):41–49. doi: 10.1016/0165-0270(83)90050-x. [DOI] [PubMed] [Google Scholar]
  27. Wirth K., Hock F. J., Albus U., Linz W., Alpermann H. G., Anagnostopoulos H., Henk S., Breipohl G., König W., Knolle J. Hoe 140 a new potent and long acting bradykinin-antagonist: in vivo studies. Br J Pharmacol. 1991 Mar;102(3):774–777. doi: 10.1111/j.1476-5381.1991.tb12249.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES